Display options
Share it on

Tomography. 2017 Mar;3(1):41-49. doi: 10.18383/j.tom.2016.00286.

A Population-Based Digital Reference Object (DRO) for Optimizing Dynamic Susceptibility Contrast (DSC)-MRI Methods for Clinical Trials.

Tomography (Ann Arbor, Mich.)

Natenael B Semmineh, Ashley M Stokes, Laura C Bell, Jerrold L Boxerman, C Chad Quarles

Affiliations

  1. Department of Imaging Research, Barrow Neurological Institute, Phoenix, Arizona.
  2. Department of Diagnostic Imaging, RI Hospital and Alpert Medical School of Brown University, Providence, Rhode Island.

PMID: 28584878 PMCID: PMC5454781 DOI: 10.18383/j.tom.2016.00286

Abstract

The standardization and broad-scale integration of dynamic susceptibility contrast (DSC)-magnetic resonance imaging (MRI) have been confounded by a lack of consensus on DSC-MRI methodology for preventing potential relative cerebral blood volume inaccuracies, including the choice of acquisition protocols and postprocessing algorithms. Therefore, we developed a digital reference object (DRO), using physiological and kinetic parameters derived from in vivo data, unique voxel-wise 3-dimensional tissue structures, and a validated MRI signal computational approach, aimed at validating image acquisition and analysis methods for accurately measuring relative cerebral blood volume in glioblastomas. To achieve DSC-MRI signals representative of the temporal characteristics, magnitude, and distribution of contrast agent-induced T

Keywords: brain tumor perfusion; digital reference object; dynamic susceptibility contrast MRI

Conflict of interest statement

Conflict of Interest: None reported.

References

  1. Phys Med Biol. 2016 Jan 21;61(2):974-82 - PubMed
  2. Radiology. 2000 Mar;214(3):912-7 - PubMed
  3. AJNR Am J Neuroradiol. 2000 May;21(5):881-90 - PubMed
  4. Tomography. 2016 Dec;2(4):295-307 - PubMed
  5. Magn Reson Imaging. 2014 Dec;32(10):1181-90 - PubMed
  6. Magn Reson Imaging. 2014 Dec;32(10):1171-80 - PubMed
  7. Top Magn Reson Imaging. 2015 Jun;24(3):127-36 - PubMed
  8. Magn Reson Med. 2012 Jul;68(1):30-40 - PubMed
  9. AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21 - PubMed
  10. AJNR Am J Neuroradiol. 2016 Aug;37(8):1440-6 - PubMed
  11. AJNR Am J Neuroradiol. 2015 Oct;36(10):E65-6 - PubMed
  12. Magn Reson Med. 2016 Jan;75(1):356-62 - PubMed
  13. Magn Reson Med. 1990 Oct;16(1):9-18 - PubMed
  14. Magn Reson Med. 1991 Feb;17(2):336-47 - PubMed
  15. Neuroimaging Clin N Am. 1999 May;9(2):309-31 - PubMed
  16. Magn Reson Med. 1998 Sep;40(3):432-42 - PubMed
  17. Magn Reson Med. 2013 May;69(5):1430-7 - PubMed
  18. AJR Am J Roentgenol. 1998 Dec;171(6):1479-86 - PubMed
  19. Magn Reson Med. 1992 Apr;24(2):375-83 - PubMed
  20. Med Health R I. 2012 Feb;95(2):42-3 - PubMed
  21. Neuroimage. 2014 Apr 1;89:262-70 - PubMed
  22. Magn Reson Imaging. 1999 Jan;17(1):21-7 - PubMed
  23. Magn Reson Med. 1990 May;14(2):249-65 - PubMed
  24. Radiology. 2003 May;227(2):593-600 - PubMed
  25. Neuro Oncol. 2013 Jul;15(7):945-54 - PubMed
  26. J Magn Reson Imaging. 1999 Aug;10(2):109-17 - PubMed
  27. PLoS One. 2014 Jan 08;9(1):e84764 - PubMed
  28. Neuro Oncol. 2015 Aug;17 (8):1148-56 - PubMed
  29. J Cereb Blood Flow Metab. 2013 May;33(5):732-43 - PubMed
  30. Magn Reson Med. 1999 Jul;42(1):167-72 - PubMed
  31. Eur Radiol. 2010 Oct;20(10):2482-90 - PubMed
  32. Magn Reson Med. 1995 Oct;34(4):555-66 - PubMed
  33. Nat Med. 2013 Sep;19(9):1178-83 - PubMed
  34. Top Magn Reson Imaging. 1999 Apr;10(2):114-24 - PubMed
  35. Magn Reson Med. 2015 Sep;74(3):772-84 - PubMed
  36. Cancer Res. 1987 Jun 15;47(12):3039-51 - PubMed
  37. Am J Clin Oncol. 2017 Jun;40(3):228-234 - PubMed
  38. Magn Reson Med. 2016 Aug;76(2):613-25 - PubMed
  39. AJNR Am J Neuroradiol. 2016 Jul;37(7):1237-43 - PubMed
  40. J Cereb Blood Flow Metab. 2011 Oct;31(10 ):2041-53 - PubMed
  41. J Mal Vasc. 1995;20(3):203-14 - PubMed
  42. Magn Reson Med. 2000 Oct;44(4):563-74 - PubMed
  43. Magn Reson Med. 1994 Jan;31(1):9-21 - PubMed
  44. Magn Reson Med. 1988 Feb;6(2):164-74 - PubMed
  45. Phys Med Biol. 2009 Oct 7;54(19):5749-66 - PubMed
  46. AJNR Am J Neuroradiol. 2004 May;25(5):746-55 - PubMed
  47. Radiology. 1994 Apr;191(1):41-51 - PubMed
  48. Magn Reson Med. 2005 Jun;53(6):1307-16 - PubMed
  49. Radiology. 2008 Nov;249(2):601-13 - PubMed
  50. Magn Reson Med. 2015 Jan;73(1):325-41 - PubMed
  51. AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98 - PubMed
  52. J Comput Assist Tomogr. 1999 Mar-Apr;23(2):232-7 - PubMed
  53. PLoS One. 2013 Jun 28;8(6):e67466 - PubMed
  54. Neuro Oncol. 2016 Apr;18(4):467-78 - PubMed
  55. Magn Reson Med. 1995 Jul;34(1):4-10 - PubMed
  56. AJNR Am J Neuroradiol. 2001 Nov-Dec;22(10):1915-9 - PubMed
  57. Magn Reson Med. 1994 Jun;31(6):601-10 - PubMed
  58. Neuro Oncol. 2015 Sep;17(9):1188-98 - PubMed
  59. Magn Reson Imaging. 2016 Nov;34(9):1248-1255 - PubMed
  60. J Magn Reson Imaging. 1997 Jan-Feb;7(1):102-10 - PubMed
  61. Magn Reson Med. 1994 Dec;32(6):749-63 - PubMed
  62. Magn Reson Med. 2003 Jul;50(1):164-74 - PubMed
  63. Radiology. 1999 Jan;210(1):269-76 - PubMed
  64. AJNR Am J Neuroradiol. 2006 Apr;27(4):859-67 - PubMed
  65. Magn Reson Med. 2001 Mar;45(3):397-408 - PubMed
  66. Magn Reson Med. 2004 May;51(5):961-8 - PubMed
  67. AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):1004-10 - PubMed
  68. Radiology. 1999 Jun;211(3):791-8 - PubMed

Publication Types

Grant support